Nyxoah SA

NYXHNASDAQHealthcareMedical Instruments & Supplies

$0.86- (-)1Y −85.50%

As of Oct 26, 2026 close

Market cap: $48.83M
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $0.90$5.96
Volume (live): -
Avg. volume (3M): 208.03K

Nyxoah SA (NYXH) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Nyxoah SA stock.

Analyst Consensus Rating

Investment consensus from 6 professional research analysts

Consensus Rating

Buy

Based on 6 unique analysts

(7 total ratings in last 90 days)

Medium Confidence∞:1 Buy/Sell

Average Price Target

$4.26

+397.43% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest NYXH Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Oct 20, 2026	Zacks Equity Research	Zacks Equity Research	Initiates Coverage	Buy	-
Oct 6, 2026	Zacks Equity Research	Zacks Equity Research	Initiates Coverage	Hold	-
Aug 17, 2026	Sarah James	Cantor Fitzgerald	Reiterates	Buy	$11.00 → $6.00 −5.00 (−45.5%)
Aug 6, 2026	Jonathan Block	Stifel Nicolaus	Reiterates	Hold	$3.00
Aug 6, 2026	Adam Maeder	Piper Sandler	Reiterates	Buy	$7.00 → $6.00 −1.00 (−14.3%)
Aug 6, 2026	David Rescott	Baird	Maintains	Hold	$2.86 → $2.31 −0.55 (−19.2%)
Aug 6, 2026	Suraj Kalia	Oppenheimer	Maintains	Buy	$13.00 → $4.00 −9.00 (−69.2%)

Zacks Equity Research

BuyInitiates Coverage

Oct 20

Zacks Equity Research

HoldInitiates Coverage

Oct 6

Sarah James

Cantor Fitzgerald

BuyReiterates

$11.00 → $6.00

Aug 17

Jonathan Block

Stifel Nicolaus

HoldReiterates

$3.00

Aug 6

Adam Maeder

Piper Sandler

BuyReiterates

$7.00 → $6.00

Aug 6

David Rescott

Baird

HoldMaintains

$2.86 → $2.31

Aug 6

Suraj Kalia

Oppenheimer

BuyMaintains

$13.00 → $4.00

Aug 6

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 20, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for NYXH?

The analyst consensus rating for NYXH is Buy, based on the latest ratings from 6 analysts over the last 90 days.

What is the average price target for NYXH?

The average 12-month price target for NYXH is $4.26, representing an upside of 397.4% from the Oct 26, 2026 close of $0.86.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.